Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Cash: 2014-2024

Historic Change in Cash for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to -$46.3 million.

  • AC Immune's Change in Cash rose 60.55% to -$7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.4 million, marking a year-over-year decrease of 341.83%. This contributed to the annual value of -$46.3 million for FY2024, which is 184.72% down from last year.
  • As of FY2024, AC Immune's Change in Cash stood at -$46.3 million, which was down 184.72% from $54.7 million recorded in FY2023.
  • Over the past 5 years, AC Immune's Change in Cash peaked at $54.7 million during FY2023, and registered a low of -$86.0 million during FY2021.
  • Its 3-year average for Change in Cash is -$14.9 million, with a median of -$46.3 million in 2024.
  • In the last 5 years, AC Immune's Change in Cash slumped by 192.29% in 2020 and then spiked by 202.95% in 2023.
  • Over the past 5 years, AC Immune's Change in Cash (Yearly) stood at -$35.4 million in 2020, then crashed by 143.09% to -$86.0 million in 2021, then surged by 38.28% to -$53.1 million in 2022, then skyrocketed by 202.95% to $54.7 million in 2023, then slumped by 184.72% to -$46.3 million in 2024.